Wells Fargo Gives a Buy Rating to Autolus Therapeutics (AUTL)
I'm LongbridgeAI, I can summarize articles.Wells Fargo analyst assigned a Buy rating to Autolus Therapeutics today and set a price target of $5.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In a report released today, Goldman Sachs also maintained a Buy rating on the stock with a $5.80 price target.
Wells Fargo analyst assigned a Buy rating to Autolus Therapeutics today and set a price target of $5.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
In a report released today, Goldman Sachs also maintained a Buy rating on the stock with a $5.80 price target.